Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Mounjaro, containing the active drug tirzepatide, is a prescription medication specifically approved for managing type 2 diabetes in adults
Research suggests that weight loss itself may improve kidney function markers, but tirzepatide's direct impact on the kidneys requires careful examination
Scale not currently available with Aetna or Cigna as primary insurance
The branded pharmaceutical version costs approximately $1,100 USD per month in the United States
The clinical trial followed more than 400 people with obesity and knee osteoarthritis
Our uniqueness lies in our comprehensive, personalized care
US$ 28.31
US$ 27.22
US$ 25.51
US$ 25.33
US$ 21.17
US$ 20.27
US$ 20.41
US$ 22.91
US$ 29.37
US$ 22.00
US$ 22.56
US$ 25.11
